Study could lead to blood-based diagnostic test for schizophrenia
Scientists at Sanford Burnham Prebys have discovered how levels of a protein could be used in the future as a […]
» Read moreStrokes, which occur when the blood supply to part of our brain is interrupted or reduced, are the leading cause […] Cardiff, UK – 11th March 2021 – EKF Diagnostics, the global in vitro diagnostics company, announces the global launch of […] COVID-19 does not pose a threat to the safety of the United States’ blood supply under existing donor screening guidelines, […] While it has been said that the eyes are a window to the soul, a new study shows they could […] The investigators used machine learning to predict which patients might get worse and not respond positively to being turned onto […] Next-generation gene sequencing (NGS) technologies –in which millions of DNA molecules are simultaneously but individually analyzed– theoretically provides researchers and […] Today, the U.S. Food and Drug Administration authorized marketing of a new device indicated for use in patients 18 and […] Amidst the continued surge of coronavirus disease (COVID-19) cases, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), vaccination […] Johnson & Johnson asked other vaccine makers to join a study of blood clot risks, but Pfizer and Moderna DECLINED […]
New stroke rehabilitation pattern based on brain-computer interface and robot technology
EKF globally launches STAT-Site® WB β-ketone and glucose handheld analyzer
U.S. blood supply is safe from coronavirus, study finds
Retinal scans tie blood vessel deterioration to genetic marker for Alzheimer’s disease
AI methods predict COVID-19 patient outcomes using routine clinical data from ICUs
Researchers develop new technology to reduce high error rates in gene sequencing
FDA authorizes marketing of a new device for use in patients undergoing stroke rehabilitation
Research says benefits of continuing immunization of front-line workers in BC with AstraZeneca vaccine far outweigh risks
J&J asked other vaccine makers to join a study of blood clot risks
